natural glp 1 receptor agonists GLP-1 for individualized treatment of type 2 diabetes mellitus GLP-1 Receptor Agonists as Treatments

Evidence based on recent studies Initially, cases of intestinal obstruction associated with GLP-1 RAs were reported by the European Medicines Agency (EMA) in 2013 [9], and this safety signal is currently being monitored by the United States (US) FDA

RA, receptor agonist

Q: What are the side effects of GLP-1 receptor agonists for psoriasis and psoriatic arthritis

Two studies have investigated the effects of GLP-1 and GLP-1 receptor agonist treatment on several aspects of kidney physiology as measured by multiparametric kidney MRI

Enebo LB, Berthelsen KK, Kankam M et al (2021) Safety, tolerability, pharmacokinetics, and pharmacodynamics of concomitant administration of multiple doses of cagrilintide with semaglutide 2.4 mg for weight management: a randomised, controlled, phase 1b trial

doi:10.1007/s40620-020-00738-9 100